Dopamine D1- Thiab D2-zoo li Receptors Tawm Tsam Txoj Cai Lij Choj Los Ntawm Kev Txwv Kev Noj Qab Haus Huv Hauv Cistanche
Mar 03, 2023
Abstract
Keeb kwm: Txawm hais tias tsis ntev los no kev nce qib hauv kev nkag siab txog cov txheej txheem molecular tswj kev laus thiab kev ua neej, thiab txoj hauv kev koom nrog kev khaws cia hauv ntau hom, kev nkag siab tag nrho ntawm cov txheej txheem kev laus tsis tau mus txog. Tshwj xeeb, cov pov thawj nce ntxiv qhia txog lub luag haujlwm tseem ceeb rau lub paj hlwb hauv kev tswj hwm lub neej, nrog rau kev hnov mob neurons, nrog rau serotonin thiab GABA signaling, tau pom tias tswj kev ua neej nyob hauvCistanche. Txawm li cas los xij, kev koom tes ntawm lwm yam neural yam tseem ceeb thiab kev nkag siab dav ntawm lub luag haujlwm ntawm lub paj hlwb hauvtswj kev laustswj kev laus hauv Cistanche.
Cov txiaj ntsig: Peb tshaj tawm tias kev hloov pauv ntawm DOP-4, ib qho dopamine D1-zoo li receptor (D1R), thiab DOP-2, dopamine D2-zoo li receptor (D2R) oppositely cuam tshuam lifespan, ceev lub cev txav ncua ncua sij hawm, kev yug me nyuam lifespan, thiab kev loj hlob ntawm Cistanche. Ua kom D2R siv aripiprazole, ib qho tshuaj tiv thaiv kev puas siab puas ntsws, ua kom ntev ntev ntawm kev ua neej thiab kev noj qab haus huv. Conversely, inhibition ntawm D2R siv quetiapine shortened worm lifespan, ntxiv txhawb lub luag hauj lwm ntawm dopamine receptors nyob rau hauv lifespan txoj cai. Mechanistically, D2R signaling tswj lub neej dhau los ntawm kev txwv kev noj zaub mov uas tau kho los ntawm AAK-2-DAF-16 txoj hauv kev.
DAG-PKC/PKD txoj hauv kev sib txuas cov teeb liab ntawm dopamine receptors thiab downstream AAK-2-DAF-16 txoj hauv kev los xa cov teeb liab mus ntev. Cov ntsiab lus: Cov ntaub ntawv no tau qhia txog lub luag haujlwm tshiab ntawm dopamine receptors hauv kev ua neej nyob thiab kev txwv kev noj haus. . Cov kws kho mob pom zoo antipsychotic aripiprazole tuav lub peev xwm ua cov tshuaj tshiab los tiv thaiv kev laus.
Ntsiab lus: Dopamine, Lifespan,Cistanche, Aripiprazole, Kev txwv kev noj haus

Nyem qhov no Mus Yuav Anti-aging Cistanche Extract
Keeb kwm ntawm Cistanche ntawm lubkev laus:
Cov txheej txheem lom neeg ntawm kev laus tseem tsis tau nkag siab zoo, txawm hais tias muaj ntau txoj kev tswj hwm kev laus uas tau txheeb xyuas los ntawm cov poov xab rau tib neeg [1]. Cov ntaub ntawv pov thawj ntxiv qhia tias lub paj hlwb ua lub luag haujlwm tseem ceeb hauv lub cevkev laus. Piv txwv li, cov kev tshawb fawb tau pom tias kev hnov mob neurons ua lub luag haujlwm tseem ceeb hauv kev tswj lub neej [2, 3].
Serotonin teeb liab tau tshaj tawm rau antagonistically hloov kho lub neej ntev los ntawm kev sib txawv serotonin receptors [4]. Tsis ntev los no, inhibitory neuron gamma-aminobutyric acid (GABA) signaling kuj tau pom los tswj kev ua neej nyob hauv Cistanche [5]. Txawm li cas los xij, ntau qhov tseem yuav tau kawm txog lub luag haujlwm ntawm lub paj hlwb hauv kev tswj hwm kev laus.
Seb lub dopamine systemtswj cov txheej txheem kev lausthiab lifespan tsis meej. Dopamine yog ib tug biogenic amine neurotransmitter, uas feem ntau modulates coj cwj pwm outputs teb rau tej yam kev mob [6, 7]. Piv txwv li, dopamine system ua haujlwm hauv kev coj cwj pwm zoo li kev nrhiav khoom plig thiab lub cev
mobility thiab paub tias yuav yooj yim rau covcuam tshuam ntawm kev laus. Thaum tso tawm los ntawm presynaptic terminals, dopamine activates ob chav kawm ntawm G protein-coupled receptors: D1 thiab D2 chav kawm ntawm dopamine receptors [8]. Hauv Cistanche: DOP-1 thiab DOP-4 yog D1-zoo li dopamine receptors (D1R), thaum DOP-2 thiab DOP-3 yog D{{ 10}zoo li dopamine receptors (D2R) [9–11].
Ib txoj kev tshawb fawb yav dhau los tau pom tias cov kab mob uas muaj kev hloov pauv hauv dopamine biosynthesis gene cat-2 muaj lub neej ib txwm muaj, qhia tias tsuas yog txo cov dopamine ntau lawm tsis cuam tshuam rau lub neej ntev [4]. Txawm li cas los xij, vim tias D1R thiab D2R tawm tsam tswj hwm ntau tus cwj pwm hauv Cistanche, suav nrog kev txiav txim siab, basal qeeb qeeb, thiab zaub mov teb [12–14], nws yog ib qho tseem ceeb los txiav txim siab txog lub luag haujlwm tshwj xeeb ntawm txhua tus dopamine receptors hauv kev tswj lub neej. ntawm Cistanche. Vim nws luv luv lifespan, soj ntsuam lub hnub nyoog phenotypes, thiab kev txuag kev laus-txog kev lom neeg txoj kev [15, 16], Cistanche yog ib qho ntawm feem ntau siv cov kab mob los kawm txog kev laus. Txawm hais tias nws yooj yim lub paj hlwb, Cistanche muaj ib qho kev txuag dopamine rau ntawm lub paj hlwb, nrog rau biosynthetic enzymes lub luag hauj lwm rau dopamine synthesis, mechanisms rau synaptic tso, thiab kev qhia ntawm dopamine receptors [17]. Cov yam ntxwv no ua rau Cistanche ib qho qauv tsim qauv tsim rau kev tshawb xyuas lub luag haujlwm ntawm dopamine system nyob rau hauv lub neej ntev.

In the present study, we demonstrate that dopamine D1- and D2-like receptors oppositely regulate worm lifespan through a dietary restriction (DR) mechanism. Using molecular genetics approach and pharmacological tools, we teased out how dopamine receptors send longevity signals through their G-protein-coupled signaling transduction pathways to downstream DR-related pathways. Our findings uncover a novel mechanism of dopamine signaling in DR and lifespan regulation. Notably, aripiprazole, a clinically widely used antipsychotic drug, robustly extends both the lifespan (>50%) and healthspan (>80 feem pua) ntawm Cistanche los ntawm kev ua kom cov dopamine receptor-mediated txoj kev. Qhov kev tshawb pom xav tsis thoob ntawm aripiprazole tuav cov lus cog tseg rau kev txhim kho ntxiv raws li qhov muaj peev xwm muaj kev nyab xeeb, tshiab tshuaj tiv thaiv kev laus.
Cov txiaj ntsig ntawm Cistanche ntawm Anti-aging
Dopamine D1- thiab D2-zoo li receptors muaj qhov cuam tshuam rau lub neej ntawm Cistanche.Rau lub luag haujlwm ntawm txhua tus dopamine receptor nyob rau hauv cov kab mob cab, cov kab mob cab uas muaj kev hloov pauv ntawm txhua plaub dopamine receptor noob, suav nrog dop-1, dop-2, dop-3, thiab dop-4, tau siv rau kev ntsuas lub neej. Intriguingly, cov dop-2 mutant pom qhov txo qis lifespan (−11.8 feem pua , P < 0.0001) dua N2
tsiaj, whereas dop {{0}} mutant tau ntev heev (ntxiv rau 29.4 feem pua , P <0.0001) piv nrog N2 tsiaj. Te dop-1 thiab dop-3 mutants kuj pom cov kev hloov pauv hauv lub neej (ntawm ntxiv rau 5.9 feem pua thiab −8.8 feem pua , feem) piv nrog cov tsiaj N2, uas tsis yog qhov tseem ceeb (P=0. 0765, P=0.2468, raws, Fig. 1A). Tese cov ntaub ntawv qhia tau hais tias kev taw qhia los ntawm D2R (DOP-2) txuas ntxiv lub neej thaum lub teeb liab los ntawm D1R (DOP-4) ua rau nws luv. Te tsis muaj qhov tseem ceeb hauv dop-1 thiab dop-3 hloov pauv hloov pauv hauv lub neej qhia tias DOP-4 thiab DOP-2 yog cov subtypes loj ntawm D1R thiab D2R hauv kev tswj hwm lifespan, raws.
Kev ncua sij hawm ntev tau cuam tshuam nrog kev ua haujlwm qeeb qeeb thiab kev laus zuj zus, nrog rau kev txhim kho qeeb [18-20]. Txhawm rau nkag siab ntxiv txog lub luag haujlwm ntawm dopamine receptors nyob rau hauv cov txheej txheem kev laus, peb txuas ntxiv mus kuaj lub cev nrawm nrawm, kev ua neej muaj menyuam, thiab kev loj hlob ntawm cov mutants.
Piv nrog rau N2 tsiaj, dop-2 mutant pom lub neej luv luv thiab lub cev txav nrawm dua li N2 tsiaj, qhov dop-4 mutant muaj qhov ncua sij hawm ua me nyuam thiab lub cev txav nrawm (Daim duab 1B -D). Dop -2 mutant tsim
sai dua, qhov dop-4 mutant pom qhov kev loj hlob qeeb (Daim duab 1D). Tese cov ntaub ntawv ntxiv txhawb nqa lub tswv yim hais tias tshwj xeeb dopamine receptors ua lub luag haujlwm xaiv thiab tshwj xeeb hauv kev tswj hwm lub neej.
Pharmacological activation los yog inhibition ntawm D2R exerts opposite teebmeem rau lub neej ntawm Cistanche.To ntxiv kom paub meej tias lub luag hauj lwm ntawm D2R nyob rau hauv ncua lifesspan nyob rau hauv Cistanche, ib tug pharmacological txoj kev uas siv aripiprazole, ib tug D2R agonist, thiab quetiapine, ib tug D2R antagonist, tau siv los txiav txim qhov cuam tshuam rau worm lifespan [21, 22]. Cov kab tsiaj qus N2 tau kho nrog aripiprazole thiab quetiapine ntawm qhov ntau ntawm 3 txog 100 μM. Lub neej ntev ntev tau pom nyob rau hauv cov kab mob aripiprazole kho. Aripipra zole ntawm 3 μM concentration tau txuas ntxiv lub neej nruab nrab ntawm N2 worms los ntawm 21.1 feem pua (P <0.0001).
Cov kab mob kis rau 100 μM ntawm aripiprazole tau mus txog qhov kev ncua ntev tshaj plaws txog li 52.6 feem pua (P <0.0001) (Fig. 2A). Nyob rau hauv sib piv, quetiapine kev kho mob koob tshuaj-dependently shortened worm lifespan (Fig. 2B). Dose-response curves muaj nyob rau hauv daim duab 2C. Tese tshawb pom ntxiv, txhawb nqa lub luag haujlwm tseem ceeb ntawm D2R hauv kev tswj cov kab mob worm lifespan.

Fig. 1 Dopamine D1- thiab D2-zoo li receptors oppositely tswj lifespan hauv Cistanche. Kev ciaj sia nyob ntawm cov kab mob sib txawv ntawm cov kab mob sib txawv ntawm 20 degree (cov kab mob sib kis tau muab piv nrog cov tsiaj qus N2: ns=tsis tseem ceeb; **** qhia P<0.0001, log-rank test). B Fast body movement spans of different worm strain cultured at 20 °C (mutant strains were compared with the N2: **, P <0.01, log-rank test). C Progeny produced per day by different worm strains. D The number of worms with different reproductive lifespans. E The developmental stage of different worm strains reached 2.5 days post-hatching. (see Additional fle 2 for supporting data). Experiments were performed in three independent biological replicates

Aripiprazole ncua lub neej ntawm Cistanche
los ntawm DOP-2 Txhawm rau txiav txim siab seb aripiprazole-mediated lifespan extension yog nyob ntawm D2R, peb frst sim cov tshuaj ntawm dopamine synthesis-tsis muaj mutant miv-2. Aripiprazole ua tsis tau tejyam ncua lub neej nyob rau hauv miv -2 mutant (Fig. 3A), qhia hais tias lub lifespan extension nyhuv ntawm aripiprazole yuav tsum tau dopamine signaling. Peb tom ntej no ua haujlwm dop-2; dop-3 ob chav mutant thiab pom tias nws yog insensitive rau aripiprazole kev kho mob (Fig. 3B).
Txhawm rau tshawb xyuas qhov twg ntawm ob tus neeg txais txiaj ntsig no pab txhawb rau lub neej txuas ntxiv, peb tau sim txhua tus mutant. Cov txiaj ntsig tau pom tias aripiprazole tsis tau txuas ntxiv lub neej ntawm dop -2 mutant (Fig. 3C), thaum lub dop -3 mutant tau pom tias muaj kev ua neej nyob ntev ntev ntawm kev kho aripiprazole (Fig. 3D). Tese tshawb pom tau pom tias kev ncua ntev ntawm kev ua neej los ntawm aripiprazole tau raug lees paub los ntawm nws qhov kev txiav txim ntawm DOP-2.
Aripiprazole mediates lifespan extension los ntawm D2R signaling
DOP-2 teeb liab los ntawm G o txoj kev [8, 23]. Txhawm rau txheeb xyuas DOP-2 downstream effectors mediating lub aripiprazole-induced pro-longevity effect, peb thawj zaug sim ib mutant tsis muaj GOA-1, Cistanche ortholog ntawm G o protein [24]. Raws li qhov xav tau, GOA-1 yog xav tau rau aripiprazole-induced extension ntawm lifespan (Fig. 4A). D2R inhibits adenylyl cyclase thiab yog li inhibits zus tau tej cov intracellular cyclic AMP (cAMP) thiab cov kev ua ntawm protein kinase A (PKA) [25]. Txoj hauv kev cAMP-PKA tau pom tias muaj kev sib haum xeeb rau lub neej thiab DR cov lus teb [26–28]. acy{16}} encodes adenylyl cyclase thiab tswj cAMP ntau lawm hauv Cistanche [29]. Te Cistanche genome encodes PKA catalytic subunit (KIN{18}}) thiab PKA regulatory subunit (KIN{19}}) [30–32]. Kev khi ntawm cAMP rau KIN-2 tau tshwm sim hauv kev tso tawm ntawm KIN nquag-1 [29]. Cov txiaj ntsig tau pom tias lub neej ncua ntev los ntawm kev kho aripiprazole tsuas yog ib feem ntawm ACY-1 thiab KIN-1 (Fig. 4B, C).

Fig. 2 Pharmacological activation lossis inhibition ntawm D2R exerts opposite efects ntawm lub neej ntawm Cistanche. Cov kab mob ciaj sia taus ntawm cov tsiaj qus-hom (N2) kab mob kab mob ntawm 20 degree ntawm NGM daim hlau uas muaj qhov sib txawv ntawm aripiprazole (Ari). Kev kho DMSO tau siv los ua kev tswj hwm. B Ciaj sia nyob nkhaus ntawm N2 worms kho nrog qhov qhia tau hais tias muaj ntau ntawm quetiapine (Que) lossis DMSO ntawm 20 degree. (Kev kho aripiprazole thiab quetiapine tau muab piv nrog kev kho DMSO: ** qhia P<0.01. ***, P <0.001. ****, P <0.0001, log-rank test). C Dose-response curve of aripiprazole (Ari) and quetiapine (Que) treatment. (see Additional fle 2 for supporting data). Experiments were performed in three independent biological replicates

Fig. 3 Aripiprazole extends the lifespan of Cistanche through DOP-2. Survival curves of mutant cat-2 (A); dop-2; dop-3 (B); dop-2 (C); dop-3 (D) treated with 100μM of aripiprazole or DMSO at 20 °C (comparison between DMSO and aripiprazole (Ari) treatment: ns=not significant with P >0.05; **** qhia P<0.0001, log-rank test) (see Additional fle 2 for supporting data). Experiments were performed in three independent biological replicates

encodes plaub PKC homologs (tpa-1, pkc-1, pkc-2 thiab pkc-3) thiab ob PKD homologs (dkf-1 thiab dkf{{5} }) [5]. Ntawm plaub PKC homologs, pkc-1, pkc-3 thiab tpa- 1 yog xav tau rau aripiprazole kom ncua lub neej, hos pkc-2 yog siv tau (Fig. 4E–H) . Rau ob lub PKD homologs, aripiprazole-mediated lifespan extension yog nyob ntawm dkf-1 es tsis yog dkf-2 (Fig. 4I, J). Tese fndings tau qhia tias aripiprazole tuaj yeem txuas lub neej ntev los ntawm PKC thiab PKD. Txhawm rau ntxiv dag zog lub luag haujlwm ntawm DGK-PKC / PKD txoj hauv kev, peb kuj tau sim egl-30 thiab egl{18}} mutants, ob qho tib si yuav tsum muaj kev cuam tshuam DAG ntau lawm thiab yog li txo PKC / PKD kev ua haujlwm [34]. Raws li qhov xav tau, aripiprazole ua tsis tiav rau kev ua neej nyob ntev hauv ob qho tib si mutants (Fig. 4K, L), ntxiv txhawb nqa lub luag haujlwm tseem ceeb ntawm DGK PKC / PKD txoj hauv kev hauv aripiprazole-mediated lifespan extension. Noj ua ke, aripiprazole mediates lub neej yias txuas ntxiv los ntawm GOA-1-DGK-1-PKC/PKD, tab sis tsuas yog ib feem nyob ntawm txoj kev cAMP-PKA. Aripiprazole ncua cov kab mob ntev ntev los ntawm Kev Txwv Kev Noj Qab Haus Huv (DR) mechanism DR robustly ncua cov txheej txheem kev laus hauv ntau lub spe cies [38]. Ob peb DR-hais txog phenotypes hauv Cistanche suav nrog kev noj qab haus huv ntxiv, txo tus cwj pwm noj, txo tus me nyuam, lub sij hawm tsim tawm ntev, thiab txo cov lipid cia [39, 40]. Yog li ntawd, peb xav paub seb dopamine signaling thiab aripiprazole kev kho mob tuaj yeem hloov kho lub neej los ntawm DR mechanisms. Peb frst sim aripiprazole ntawm ib tug ntev nyob noj -2 mutant, ib tug genetic qauv ntawm DR nrog ib tug decit nyob rau hauv pharyngeal pumping [41]. Aripiprazole tsis tau plaub hau kom ntev lub neej ntawm kev noj mov -2 mutant (Fig. 5A), qhia tau hais tias lub neej kev pab cuam ntawm aripiprazole yog tiag conferred los ntawm ib tug DR mechanism. Ob peb DR-hais txog phenotypes kuj tau tshuaj xyuas. Dhau li ntawm kev ncua ntev, kev noj qab haus huv cuam tshuam qhov zoo ntawm kev ncua ntev kuj tseem ceeb heev rau kev noj qab haus huv laus. Aripiprazole tau nce kev noj qab haus huv ntawm Cistanche nyob rau hauv ib koob tshuaj-raws li cou pled nrog nws cov nyhuv ntawm lifespan. Aripiprazole ntawm 100 μM ua rau muaj qhov nce siab tshaj plaws (87.5 feem pua) ntawm kev noj qab haus huv ntawm N2 tsiaj (Fig. 5B). Aripiprazole kev kho mob kuj txo tag nrho cov progeny tsim ib kab cab, txawm tias muaj lub sij hawm ncua ntxiv (Fig. 5C, D). Tsis tas li ntawd, cov roj liab O staining tau pom tias aripipra zole-kho kab mob tau txo cov lipid tsub zuj zuj (Daim duab 5E, F). Pharyngeal pumping tus nqi zoo corre lig nrog cov khoom noj khoom haus hauv Cistanche. Ib qho laj thawj ncaj qha ntawm DR-zoo li qhov tshwm sim yog txo cov khoom noj uas tshwm sim los ntawm qhov txo qis ntawm pharyngeal pumping npaum li cas, zoo li pom hauv kev noj mov -2 mutant. Raws li pom nyob rau hauv daim duab 5G, aripipra zole kho N2 worms pom ib tug txo pharyngeal twj tso kua mis, ntxiv hais tias aripiprazole trig gered ib tug DR-zoo li lub xeev nyob rau hauv Cistanche.

Fig. 5 Aripiprazole ncua cov kab mob ntev los ntawm kev txwv kev noj haus. Kev ciaj sia nyob nkhaus ntawm noj-2 mutant kho nrog 100μM
of aripiprazole (Ari) or DMSO at 20 °C (comparison between DMSO and Ari treatment: ns=not signifcant, P >0 .05. **, P<0.01. ****, P <0.0001, log-rank test). B Fast body movement spans of wild-type (N2) worms cultured at 20 °C on NGM plates containing indicated concentrations of aripiprazole (Ari) or DMSO. C, D Changes in brood size (C) and reproductive span (D) of N2 animals treated with or without 100μM of aripiprazole (Ari) (comparison between DMSO and aripiprazole (Ari) treatment: ****, P <0.0001, t-test). E Representative images of ORO staining of worms treated with or without aripiprazole (Ari) for 7days. Scale bar=200μm. F Relative ORO intensity of worms treated with or without aripiprazole for 7days (comparison between DMSO and aripiprazole (Ari) treatment: ****, P <0.0001, t-test). G Pharyngeal pumping rate of N2 worms treated with 100μM of aripiprazole (Ari) or DMSO for 5days (comparison between DMSO and Ari treatment: **** indicated P <0.0001, t-test). (see Additional fle 2 for supporting data). The brood size assay was performed in two independent biological replicates. Other experiments were performed in three independent biological replicates

Aripiprazole mediates DR-zoo li lub neej ncua ntev los ntawm txoj kev AAK-2-DAF-16. Txhawm rau txuas ntxiv cov txheej txheem ua tau ntawm aripiprazole-mediated DR-like lifespan extension, peb tau tshuaj xyuas DAF-16, Cistanche homolog ntawm mammalian FOXO transcription Qhov tseem ceeb paub tias ua lub luag haujlwm tseem ceeb hauv kev ua neej nyob thiab DR kev cai [42]. Remarkably, lub neej ncua kev tshwm sim ntawm aripiprazole raug tshem tawm tag nrho hauv daf-16 mutant (Fig. 6A). DAF-16 nyob hauv cyto sol nyob rau hauv ib txwm muaj. Thaum qhib tau lawm, DAF-16 yuav hloov mus rau lub nucleus kom ua rau lub tran scription ntawm ntau yam noob uas tswj kev ntxhov siab,
metabolism, kev yug me nyuam, thiab kav ntev. Tseeb tiag, TJ356 kab mob nrog ntsuab fluorescent protein (GFP)-tagged DAF-16 tau pom tias muaj kev nce ntxiv ntawm DAF-16 hauv lub nucleus ib zaug kho nrog aripiprazole (Fig. 6B, C), qhia tias aripiprazole mediates DR. -zoo li lifespan
txuas ntxiv los ntawm DAF-16.Nyob rau hauv DR-zoo li mechanism, insulin/insulin-zoo li kev loj hlob yam 1 (IGF-1) signaling, ntsiag to cov ntaub ntawv regulator

Fig. 6 Aripiprazole mediates DR-like lifespan extension through the AAK-2-DAF-16 pathway. A Survival curve of the daf-16 mutant treated with 100μM of aripiprazole (Ari) or DMSO at 20 °C (comparison between DMSO and aripiprazole (Ari) treatment: ns=not signifcant with P >0.05, xeem-qib xeem). B Cov duab sawv cev ntawm cov cab uas muaj cytosolic, nruab nrab, thiab nuclear DAF-16 localization hauv TJ356 transgenic hom. Scale bar =50μm. C Qhov feem pua ntawm TJ356 cov tsiaj kho nrog 100μM aripiprazole (Ari) lossis DMSO tso tawm cytosolic, nruab nrab, lossis nuclear localization. D–J Survival curves of mutant daf-2 (D), age-1 (E), akt-1 (F), akt-2 (G), sir{{ 12}}.1 (H), aak-2 (I), par-4 (J) kho nrog 100μM ntawm aripiprazole
(Ari) or DMSO at 20 °C (comparison between DMSO and aripiprazole (Ari) treatment: ns=not significant with P >0.05. ** hais p<0.01. ****, p<0.0001, log-rank test) (see Additional fle 2 for supporting data). Experiments were performed in three independent biological replicates
rau N2 tsiaj (Fig. 6H), qhia tau hais tias aripiprazole-mediated lifespan extension kuj yog ywj siab ntawm SIR-2.1.
Aripiprazole tau pom tias ua kom cov tsiaj txhu AMPK hauv PC12 hlwb [43, 44]. Peb, yog li ntawd, xav tias aripiprazole tuaj yeem ua haujlwm los ntawm AAK-2 los kho qhov txuas ntxiv ntawm kev ua neej. Raws li pom nyob rau hauv daim duab 6I, aripiprazole ua tsis tau tejyam kom ncua lub neej ntawm aak-2
mutant, qhia tias aak-2 yuav tsum tau rau cov teebmeem ntawm ripiprazole ntawm lifespan. Peb tau sim ntxiv ib qho mutant uas muaj kev hloov pauv hauv Cistanche siab kinase B1 (LKB1) homolog PAR-4, ib qho dej ntws ntws ntawm AMPK. Lub par-4 mutant tso tawm tsis pub dhau lub neej ncua raws li aripiprazole-kev kho mob (Daim duab 6J), uas txhawb ntxiv qhov kev xav tias aripiprazole-mediated lifespan extension yuav tsum muaj cov haujlwm ntawm AAK-2.
Nug ntau ntxiv: Email:wallence.suen@wecistanche.com Whatsapp ntxiv rau 86 15292862950






